Comments
Biogen Lou Gehrig's disease drug fails in key trial
04.01.2013. | (Reuters) - An experimental drug to combat amyotrophic lateral sclerosis, commonly called Lou Gehrig's disease in the United States, failed to work in an important trial and Biogen Idec said it would stop development of the treatment....
